STICHTING VU

Their core work

Vrije Universiteit Amsterdam (VU) is a major Dutch research university with deep strengths in life sciences, neuroscience, toxicology, and environmental science. They translate fundamental research into applied outcomes across health, digital, and environmental domains — from brain simulation and neuromorphic computing to chemical risk assessment and ecosystem services mapping. VU is also a significant training hub, running numerous Marie Skłodowska-Curie networks that develop the next generation of researchers across Europe. Their work spans from molecular-level microscopy and genomics to large-scale climate adaptation and data integration platforms.

What they specialise in

How they've shifted over time

In the early H2020 period (2014–2018), VU's work was broadly distributed across health systems, personalised medicine, climate change adaptation, big data integration, and fundamental life sciences. The recent period shows a sharp consolidation around toxicology and adverse outcome pathways, brain simulation (neuroinformatics, neuromorphic computing, neurorobotics), and computational methods including simulation and machine learning. This shift signals a move from broad exploratory research toward computationally intensive, applied safety and neuroscience domains.

VU is converging on computational safety science (toxicology, adverse outcome pathways) and brain-inspired computing — expect future consortia around AI-driven risk assessment and digital neuroscience platforms.

How they like to work

VU acts as both a strong coordinator (103 of 254 projects) and a reliable consortium partner, showing versatility in project leadership. With 1,801 unique partners across 68 countries, they operate as a true network hub rather than clustering around repeat collaborators. Their heavy use of MSCA training networks (41 projects) means they are experienced at managing multi-partner, cross-border research and training programmes — making them a well-organised and administratively capable partner.

VU has built one of the largest collaboration networks in H2020, with 1,801 unique consortium partners spanning 68 countries — well beyond European borders. Their Amsterdam base and international orientation make them a natural hub connecting Western European institutions with partners across all continents.

What sets them apart

VU stands out for combining deep fundamental science (microscopy, neuroscience, molecular biology) with large-scale applied programmes in chemical safety and environmental risk. Few universities match their dual strength in both coordinating major training networks and leading research-intensive projects. Their toxicology and adverse outcome pathway expertise is particularly distinctive — directly relevant for regulatory science, pharmaceutical safety, and chemical industry partners seeking science-backed risk assessment.

Highlights from their portfolio

• Lensless
  EUR 1.5M ERC-funded project coordinated by VU to develop a new generation of microscopy without lenses — represents their imaging technology leadership.
• CHROMAVISION
  EUR 1.05M coordinated project combining super-resolution microscopy with microfluidics and lab-on-a-chip — shows their ability to bridge physics and biology.
• socio-bio interplay
  EUR 1.39M ERC project investigating how social experiences affect DNA methylation — exemplifies VU's strength in interdisciplinary research connecting social and biological sciences.